Page last updated: 2024-08-25

rosiglitazone and Neoplasm Metastasis

rosiglitazone has been researched along with Neoplasm Metastasis in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (42.86)	29.6817
2010's	4 (57.14)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Goepfert, C; Hafner, J; Jandus, C; Levesque, MP; Loyon, R; Mastelic-Gavillet, B; Meylan, P; Michalik, L; Moret, C; Moser, H; Nguyen, TN; Pich, C; Romero, P; Trang, BK	1
Bantug, G; Christofori, G; Diepenbruck, M; Hess, C; Ishay-Ronen, D; Ivanek, R; Kalathur, RKR; Morini, MF; Sugiyama, N; Tiede, S; Wang, J	1
Endo, H; Fujita, K; Hosono, K; Iida, H; Ikeda, I; Inamori, M; Kubota, K; Nagashima, Y; Nakagama, H; Nakajima, A; Nakajima, N; Saito, S; Sugiyama, M; Takahashi, H; Tomimoto, A; Wada, K; Yoneda, K	1
Krieger-Hinck, N; Müller, A; Schumacher, U; Valentiner, U	1
Colburn, D; Colevas, AD; Graham, RA; LoRusso, PM; Low, JA; Malhi, V; Mita, M; Piha-Paul, SA; Yin, M	1
Buchegger, F; Meier, CA; Petite, C; Philips, JC; Willi, JP	1
Elias, AN; Lizotte, P	1

Trials

1 trial(s) available for rosiglitazone and Neoplasm Metastasis

Article	Year
Co-administration of vismodegib with rosiglitazone or combined oral contraceptive in patients with locally advanced or metastatic solid tumors: a pharmacokinetic assessment of drug-drug interaction potential. Cancer chemotherapy and pharmacology, 2013, Volume: 71, Issue:1 Topics: Aged; Anilides; Antineoplastic Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Cohort Studies; Contraceptives, Oral, Combined; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP3A; Drug Interactions; Ethinyl Estradiol; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Norethindrone; Pyridines; Rosiglitazone; Thiazolidinediones	2013

Article

Year

Co-administration of vismodegib with rosiglitazone or combined oral contraceptive in patients with locally advanced or metastatic solid tumors: a pharmacokinetic assessment of drug-drug interaction potential.

Cancer chemotherapy and pharmacology, 2013, Volume: 71, Issue:1

Topics: Aged; Anilides; Antineoplastic Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Cohort Studies; Contraceptives, Oral, Combined; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP3A; Drug Interactions; Ethinyl Estradiol; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Norethindrone; Pyridines; Rosiglitazone; Thiazolidinediones

2013

Other Studies

6 other study(ies) available for rosiglitazone and Neoplasm Metastasis

Article	Year
Induction of Paracrine Signaling in Metastatic Melanoma Cells by PPARγ Agonist Rosiglitazone Activates Stromal Cells and Enhances Tumor Growth. Cancer research, 2018, 11-15, Volume: 78, Issue:22 Topics: Angiogenesis Inducing Agents; Animals; Carcinogenesis; Cell Line, Tumor; Fibroblasts; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Leukocytes, Mononuclear; Macrophages; Melanoma; Mice; Mice, Inbred NOD; Mice, SCID; Monocytes; Neoplasm Metastasis; Neoplasm Transplantation; Oligonucleotide Array Sequence Analysis; Paracrine Communication; PPAR gamma; Rosiglitazone; Skin Neoplasms; Stromal Cells; T-Lymphocytes	2018
Gain Fat-Lose Metastasis: Converting Invasive Breast Cancer Cells into Adipocytes Inhibits Cancer Metastasis. Cancer cell, 2019, 01-14, Volume: 35, Issue:1 Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Animals; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Transdifferentiation; Epithelial-Mesenchymal Transition; Female; Flavonoids; Humans; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Proto-Oncogene Proteins c-met; Rosiglitazone; Signal Transduction; Transforming Growth Factor beta	2019
Inhibition of peroxisome proliferator-activated receptor gamma activity suppresses pancreatic cancer cell motility. Cancer science, 2008, Volume: 99, Issue:10 Topics: Animals; Benzamides; Catenins; cdc42 GTP-Binding Protein; Cell Adhesion Molecules; Cell Line, Tumor; Cell Movement; Delta Catenin; Humans; Ligands; Mice; Mice, SCID; Neoplasm Metastasis; Pancreatic Neoplasms; Phosphoproteins; PPAR gamma; Pyridines; rac1 GTP-Binding Protein; RNA, Small Interfering; Rosiglitazone; Thiazolidinediones; Xenograft Model Antitumor Assays	2008
The effect of the PPAR-gamma agonist rosiglitazone on neuroblastoma SK-N-SH cells in a metastatic xenograft mouse model. Oncology research, 2010, Volume: 18, Issue:8 Topics: Animals; Cell Line, Tumor; Cell Proliferation; Female; Humans; Male; Mice; Mice, Inbred BALB C; Mice, SCID; Neoplasm Metastasis; Neuroblastoma; PPAR gamma; Rosiglitazone; Thiazolidinediones; Xenograft Model Antitumor Assays	2010
Effect of peroxisome proliferator-activated receptor gamma agonist, rosiglitazone, on dedifferentiated thyroid cancers. Nuclear medicine communications, 2004, Volume: 25, Issue:12 Topics: Adult; Aged; Cell Differentiation; Humans; Hypoglycemic Agents; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Pilot Projects; Positron-Emission Tomography; PPAR gamma; Prospective Studies; Rosiglitazone; Thiazolidinediones; Thyroglobulin; Thyroid Neoplasms; Time Factors; Tomography, X-Ray Computed	2004
Enhanced radioiodine uptake in a patient with poorly differentiated papillary thyroid cancer after treatment with rosiglitazone. Clinical nuclear medicine, 2006, Volume: 31, Issue:9 Topics: Cell Differentiation; Female; Humans; Hypoglycemia; Iodine Radioisotopes; Middle Aged; Neoplasm Metastasis; Peroxisome Proliferator-Activated Receptors; Radionuclide Imaging; Rosiglitazone; Thiazolidinediones; Thyroglobulin; Thyroid Neoplasms	2006